Asterion is developing novel therapeutic products (ProFuse, Third-generation AFT) with superior pharmacological profiles that will improve the current treatment options for patients with chronic and debilitating diseases
12 years ago
Fusion IP, Spirit Capital Partners
Use Asterion's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Asterion's historical monthly uniques as a proxy for mindshare and web traction.
Use Asterion's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Lamborghini debuts 910 horsepower Asterion plug-in hybrid